CGBD trades 1.5% above Wall Street's consensus target of $11.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CGBD achieves its forward estimates and maintains a stable P/E multiple of 7.8x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Carlyle Secured Lending, Inc. (CGBD) has a Wall Street consensus price target of $11.00, based on estimates from 7 covering analysts. With the stock currently trading at $11.17, this represents a potential downside of -1.5%. The company has a market capitalization of $776M.
Analyst price targets range from a low of $11.00 to a high of $11.00, representing a 0% spread in expectations. The median target of $11.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CGBD trades at a trailing P/E of 11.1x and forward P/E of 7.8x. The forward PEG ratio of 0.12 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +174.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $9.77, with bear and bull scenarios of $6.16 and $12.88 respectively. Model confidence stands at 46/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ARCCAres Capital Corporation | $13.7B | $19.13 | $19.00 | -0.7% | Buy | 10.1x | 32 |
GBDCGolub Capital BDC, Inc. | $3.3B | $12.74 | $14.25 | +11.9% | Buy | 9.3x | 12 |
TPVGTriplePoint Venture Growth BDC Corp. | $177M | $4.37 | $5.00 | +14.4% | Hold | 5.1x | 12 |
MFICMidCap Financial Investment Corporation | $845M | $10.26 | $10.50 | +2.3% | Hold | 6.9x | 14 |
OCSLOaktree Specialty Lending Corporation | $1.1B | $12.50 | $12.50 | +0.0% | Hold | 8.3x | 12 |
TRINTrinity Capital Inc. | $1.3B | $17.80 | $20.00 | +12.4% | Buy | 8.5x | 7 |
FSKFS KKR Capital Corp. | $3.3B | $11.70 | $11.75 | +0.4% | Hold | 7.2x | 13 |
PSECProspect Capital Corporation | $706M | $1.41 | $2.50 | +77.3% | Hold | 3.0x | 20 |
SLRCSLR Investment Corp. | $644M | $11.81 | $12.50 | +5.8% | Buy | 9.0x | 15 |
PFLTPennantPark Floating Rate Capital Ltd. | $683M | $6.88 | $8.75 | +27.2% | Buy | 6.5x | 11 |
Quick answers to the most common questions about buying CGBD stock.
Wall Street's consensus price target for CGBD is $11, -1.5% from its current price of $11.17. The below-market target from 7 analysts suggests limited near-term appreciation.
CGBD has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $11 implies -1.5% downside from current levels.
With a forward P/E of 7.8112x, CGBD trades at a relatively low valuation. The consensus target of $11 implies -1.5% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $11 for CGBD, while the most conservative target is $11. The consensus of $11 represents the median expectation. Our quantitative valuation model projects a bull case target of $13 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CGBD is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CGBD stock forecast based on 7 Wall Street analysts shows a consensus price target of $11, with estimates ranging from $11 (bear case) to $11 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $10, with bear/bull scenarios of $6/$13.
Our quantitative valuation model calculates CGBD's fair value at $10 (base case), with a bear case of $6 and bull case of $13. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.
CGBD trades at a forward P/E ratio of 7.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CGBD, with 0 Sell ratings and a price target of $11 (-1.5% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CGBD analyst price targets range from $11 to $11, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11 consensus represents the middle ground. Our model's $6-$13 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.